Life sciences news
-
UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results
Friday February 4th 2022
Read more
-
Large UK study shows rapid EGFR testing with Idylla™ alongside NGS has potential to enhance lung cancer patient health outcomes
Tuesday January 25th 2022
Read more
-
BIMZELX[®] (bimekizumab) approved in Japan for the treatment of plaque psoriasis, generalized pustular psoriasis and psoriatic erythroderma
Monday January 24th 2022
Read more
-
argenx announces VYVGART™ approval in Japan for the treatment of generalized myasthenia gravis
Friday January 21st 2022
Read more
-
argenx announces U.S. Food and Drug Administration (FDA) approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis
Monday December 20th 2021
Read more
-
Early detection of Omicron facilitated with Emweb's Genome Detective
Friday December 10th 2021
Read more
-
Biocartis’ Idylla™ SARS-CoV-2 testing successfully detects Omicron variant
Thursday December 9th 2021
Read more
-
Spectacular results with Japanese encephalitis vaccine of ViroVet
Wednesday December 8th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
New study demonstrates Idylla™ EGFR Mutation Test (CE-IVD) shortens time to patient management decisions for patients with non-small cell lung cancer
Tuesday November 16th 2021
Read more
-
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
Monday November 15th 2021
Read more
-
Precirix dosed first patients in Phase I/II clinical study evaluating CAM-H2 in HER2-positive metastatic cancer
Wednesday October 6th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
